Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.
This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.
TCT provides the latest evidence-based data, presented by leading physicians, nurses, and scientists, that will affect the practice of interventional cardiology and endovascular medicine. TCT showcases the practical applications of current and emerging techniques and technologies and an unparalleled diversity of Live Case presentations from universities and medical centers from around the world. In the field of interventional cardiology, only TCT combines the late-breaking science and practical education that physicians need to improve patient outcomes.
The overall goal of this activity is to improve the competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care.
By the end of the symposium, participants should be able to:
Apply the results from important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease
Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
Integrate advances in diagnostic evaluation and therapeutics into the treatment of patients with carotid and peripheral arterial disease
Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations and therefore does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.